• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Regulatory Information

  • Print
  • Share
  • E-mail

Section Two: Pharmaceutical Purchasing Organizations

Prescription Drug Marketing Act Report to Congress (2001): Back to Table of Contents 

Previous Section: 1.6 Topics Related to the Functioning of the Distribution Models

Organizations Purchasing Wholesale Drugs Products: The Demand for Wholesale Drugs

To further characterize drug distribution and drug pricing influences, this section profiles some of the organizations that purchase or are involved indirectly in the purchase of drugs. Separate discussions are provided below on health care institutions and integrated delivery networks (IDNs), pharmacy benefit management companies (PBMs), and retailers. The final section briefly addresses the influence of health maintenance organizations (HMOs) and PBMs on prescription drug prices.

Next Section: 2.1 Health Care Institutions and Integrated Delivery Networks (IDNs)